Desmond A Schatz, MD - Research

Research at a glance

Top areas of exploration

Diabetes Mellitus, Type 1 , 253 publications
Autoantibodies , 92 publications
Insulin , 68 publications
Islets of Langerhans , 49 publications

Research activity

381 publications

23,284 citations

Why is this important?

Active clinical trials

ITN095AI DESIGNATE

This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0. Participants will be randomized 1:1:1:1 to one of four possible鈥�

Investigator: Desmond A Schatz
Status: Accepting Candidates
Ages: 8 Years - 45 Years
Sexes: All

My publications

381 publications

2020

Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes.

Diabetes technology & therapeutics

鈥�

2020

Exocrine Pancreas Dysfunction in Type 1 Diabetes.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

鈥�

2020

Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study

Diabetes Care

鈥�

2020

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Diabetic medicine : a journal of the British Diabetic Association

鈥�

2020

Immune Intervention in Type 1 Diabetes.

Diabetes technology & therapeutics

鈥�

BOB体育